Stock Scorecard

Stock Summary for N/A (QNCX) - $1.03 as of 4/25/2024 9:02:35 PM EST

Total Score

3 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QNCX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QNCX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QNCX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for QNCX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for QNCX

The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech 3/8/2024 9:40:00 AM
Don't Know Much Biology? Tips for Picking Microcap Biotech, Pharma 3/7/2024 9:47:00 PM
SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying - SHF Hldgs ( NASDAQ:SHFS ) , Quince Therapeutics ( NASDAQ:QNCX ) 12/8/2023 1:50:00 PM
Over $2M Bet On This Industrial Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Quince Therapeutics ( NASDAQ:QNCX ) , Dirtt Environmental Solns ( OTC:DRTTF ) 12/4/2023 2:12:00 PM
Chief Business Officer and COO at Quince Therapeutics Acquires Company Stock Options Worth 75,000 Shares - Quince Therapeutics ( NASDAQ:QNCX ) 10/27/2023 3:00:00 PM
Quince Therapeutics Chief Scientific Officer Awarded $291K Worth of Stock Options - Quince Therapeutics ( NASDAQ:QNCX ) 10/25/2023 3:00:00 PM
Quince Therapeutics Board Member Awarded $52K Worth of Stock Options - Quince Therapeutics ( NASDAQ:QNCX ) 10/25/2023 3:00:00 PM
Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket - Brooge Energy ( NASDAQ:BROG ) , Bionomics ( NASDAQ:BNOX ) 9/29/2023 12:15:00 PM
325K Reasons To Be Bullish On Quince Therapeutics Stock - Quince Therapeutics ( NASDAQ:QNCX ) 8/18/2023 3:01:00 PM
Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying - Gaia ( NASDAQ:GAIA ) , Quince Therapeutics ( NASDAQ:QNCX ) 8/14/2023 12:45:00 PM

Financial Details for QNCX

Company Overview
Ticker QNCX
Company Name N/A
Country N/A
Description N/A
Sector Name N/A
Industry Name N/A
Most Recent Quarter N/A
Next Earnings Date N/A

Stock Price History
Last Day Price 1.03
Last Day Price Updated 4/25/2024 9:02:35 PM EST
Last Day Volume 93,060
Average Daily Volume 77,158
52-Week High 0.00
52-Week Low 0.00
Last Price to 52 Week Low 0.00%

Valuation Measures
Trailing PE N/A
Industry PE N/A
Sector PE N/A
5-Year Average PE 0.00
Free Cash Flow Ratio 0.00
Industry Free Cash Flow Ratio N/A
Sector Free Cash Flow Ratio N/A
Current Ratio Most Recent Quarter 0.00
Total Cash Per Share 0.00
Book Value Per Share Most Recent Quarter 0.00
Price to Book Ratio 0.00
Industry Price to Book Ratio N/A
Sector Price to Book Ratio N/A
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months N/A
Sector Price to Sales Ratio Twelve Trailing Months N/A

Share Statistics
Total Shares Outstanding 0
Market Capitalization 0
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 0.00%
Reported EPS 12 Trailing Months 0.00
Reported EPS Past Year 0.00
Reported EPS Prior Year 0.00
Net Income Twelve Trailing Months 0
Net Income Past Year 0
Net Income Prior Year 0
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet
Total Cash Most Recent Quarter 0
Total Cash Past Year 0
Total Cash Prior Year 0
Net Cash Position Most Recent Quarter 0
Net Cash Position Past Year 0
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year 0
Total Stockholder Equity Prior Year 0
Total Stockholder Equity Most Recent Quarter 0

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.05
MACD Signal -0.05
20-Day Bollinger Lower Band 0.94
20-Day Bollinger Middle Band 1.18
20-Day Bollinger Upper Band 1.43
Beta 0.00
RSI 43.90
50-Day SMA 1.22
200-Day SMA 19.62

System
Modified 8/9/2022 6:46:41 PM EST